Xiongzheng David MU

A personal message from Dr Xiongzheng Mu

I would like to invite any practitioner interested by the facial lift topics to join us at IMCAS China, where I will chair a whole session dedicated to this procedure.

Up until mid-age, long lasting treatments will be preferred to short-term lasting procedures in order to counter muscle ptosis, laxity, and wrinkle. Facial lift is the main treatment for rejuvenation, but is not the only option.

Recently in Asia, mini-invasive surgery, injectable fillers, and lipofilling became more popular in most of the clinics. In Mainland China, mini-invasive and filler injection has increased by more than 100% in many aesthetic centers or hospitals, replacing the traditional facial lift. A few combined facial lifts can also be found in those units.

Indeed, this procedure, as many others, was subjected to great changes within this decade, following the latest great economic movements. Plastic Surgeons should thus follow this tendencies, and be up do date with the newest techniques and procedures.

That's what we are going to cover within this session, with lectures on midface and lower face update approaches, endoscope assisted facial lift, combination therapy and many more.

Finally, beyond those topics, I would like to invite you to check the whole IMCAS China program for we, the board, have been very committed to prepare a scientific program featuring the latest trends and techniques in aesthetic surgery and medicine, and satisfying to any colleague of our segment.
I really look forward to meet you all this summer during this new and exciting IMCAS China.

Welcome to Shanghai!

Dr Xiongzheng MU,
Plastic Surgeon, Shanghai Huashan Hospital
Professor at Fudan University
Chairman of APCA (Asia craniofacial)